Archive · 23 Jul 2025
Natco Pharma to Acquire South African Firm for ₹2,000 Crores
Imagine a company called Natco Pharma wants to buy part of another company in South Africa called Adcock Ingram.
They're spending about ₹2,000 crore to get over 5 crore shares.
This means Natco will own a significant part of Adcock.
Natco Pharma's shares went up slightly after they announced this purchase.
The company's stock has shown varying performance recently.
Natco Pharma is also setting up a new company in South Africa as part of this plan.
Natco Pharma to acquire shares of Adcock Ingram Holdings Ltd, South Africa.
The acquisition involves over 5.16 crore shares for approximately ₹2,000 crore.
The acquisition price is ZAR 75.00 (approximately US$ 4.27) per share.
Natco Pharma will also incorporate NATCO Pharma South Africa Proprietary Limited.
Natco Pharma shares closed 2.01% higher on Wednesday, July 23, 2025.
- Who
- Natco Pharma and Adcock Ingram Holdings Ltd.
- What
- Natco Pharma is acquiring shares of Adcock Ingram Holdings Ltd.
- When
- The acquisition was announced after market hours on July 23, 2025. The deal was approved on 24 July 2025.
- Where
- South Africa
- Why
- The reason for the acquisition is not explicitly mentioned in the provided articles.
- Acquisition Cost
- ₹2,000 crore
- Shares Acquired
- Over 5.16 crore
- Price Per Share
- ZAR 75.00 (approx. US$ 4.27)
- Closing Share Price (July 23, 2025)
- ₹1,034.75
- Share increase
- 2.01%
- Market Capitalisation (July 23, 2025)
- ₹18,533.39 crore
- 52-Week High
- ₹1,638.35 (September 12, 2025)
- 52-Week Low
- ₹660.05 (April 7, 2025)